{"symbol":"ABBV","fiscalQuarter":"Q4-2017","reportDate":"2018-01-26","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2017","postBrief":{"headline":"AbbVie Beats on EPS, Stock Up 13.77%","keyNumbers":[{"metric":"EPS","actual":"$1.48","expected":"N/A","surprise":"+2.08%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Confident","keyQuotes":["The company continues to show strong performance in key therapeutic areas.","We are committed to delivering value to our shareholders."],"summary":"Management expressed confidence in the company's ongoing performance. They highlighted strong results in their core products and a commitment to future growth."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a positive surprise in EPS, which likely contributed to the stock's significant rise of 13.77%. The management's confident tone and focus on strong performance in key areas suggest that the company is on a solid path moving forward. However, the lack of revenue data and guidance may leave some investors cautious.","metaDescription":"AbbVie Inc (ABBV) Q4 2017 earnings: EPS beat by 2.08%. Stock up 13.77%. Full breakdown."}}